You are viewing a single comment's thread.

view the rest of the comments →

jangles ago

http://archive.is/eJBNx

Nine candidates based on the COBRA technology were designed and assessed as vaccines used alone, in cocktails, or in prime-boost combinations. The most effective regimens elicited the broadest hemagglutination-inhibition (HAI) response against a panel of H1N1 viruses isolated over the past 100 years, even against viruses whose sequences were not included in the design strategy. “For current vaccines, an endpoint is the hemagglutation inhibition,” Dr. Alefantis says. “We are using the same technology and the same benchmark to induce antibodies that work against a broader number of strains.”